Investigation of Nano-Bio Interactions within a Pancreatic Tumor Microenvironment for the Advancement of Nanomedicine in Cancer Treatment

dc.contributor.authorAlhussan, Abdulaziz
dc.contributor.authorBromma, Kyle
dc.contributor.authorBozdoğan, Ece Pinar Demirci
dc.contributor.authorMetcalfe, Andrew
dc.contributor.authorKaraskinska, Joanna
dc.contributor.authorBeckham, Wayne
dc.contributor.authorAlexander, Abraham S.
dc.contributor.authorRenouf, Daniel J.
dc.contributor.authorSchaeffer, David F.
dc.contributor.authorChithrani, Devika B.
dc.date.accessioned2021-06-08T21:30:18Z
dc.date.available2021-06-08T21:30:18Z
dc.date.copyright2021en_US
dc.date.issued2021
dc.description.abstractPancreatic cancer is one of the deadliest types of cancer, with a five-year survival rate of only 10%. Nanotechnology offers a novel perspective to treat such deadly cancers through their incorporation into radiotherapy and chemotherapy. However, the interaction of nanoparticles (NPs) with cancer cells and with other major cell types within the pancreatic tumor microenvironment (TME) is yet to be understood. Therefore, our goal is to shed light on the dynamics of NPs within a TME of pancreatic origin. In addition to cancer cells, normal fibroblasts (NFs) and cancer-associated fibroblasts (CAFs) were examined in this study due to their important yet opposite roles of suppressing tumor growth and promoting tumor growth, respectively. Gold nanoparticles were used as the model NP system due to their biocompatibility and physical and chemical proprieties, and their dynamics were studied both quantitatively and qualitatively in vitro and in vivo. The in vitro studies revealed that both cancer cells and CAFs take up 50% more NPs compared to NFs. Most importantly, they all managed to retain 70–80% of NPs over a 24-h time period. Uptake and retention of NPs within an in vivo environment was also consistent with in vitro results. This study shows the paradigm-changing potential of NPs to combat the disease.en_US
dc.description.reviewstatusRevieweden_US
dc.description.scholarlevelFacultyen_US
dc.description.sponsorshipThis research was funded by Natural Sciences and Engineering Research Council of Canada, British Columbia Knowledge Development Fund, and Canadian Foundation for Innovation.en_US
dc.identifier.citationAlhussan, A., Bromma, K., Bozdoğan, E. P. D., Metcalfe, A., Karasinska, J., Beckham, W., … Chithrani, D. B. (2021). Investigation of Nano-Bio Interactions within a Pancreatic Tumor Microenvironment for the Advancement of Nanomedicine in Cancer Treatment. Current Oncolocy, 28(3), 1-18. https://doi.org/10.3390/curroncol28030183.en_US
dc.identifier.urihttps://doi.org/10.3390/curroncol28030183
dc.identifier.urihttp://hdl.handle.net/1828/13027
dc.language.isoenen_US
dc.publisherCurrent Oncolocyen_US
dc.subjectpancreatic cancer
dc.subjectgold nanoparticles
dc.subjectuptake
dc.subjectretention
dc.subjectPANC-1
dc.subjectMia PaCa-2
dc.subjectnormal
dc.subjectCentre for Advanced Materials and Related Technologies (CAMTEC)
dc.subjectCentre for Biomedical Research
dc.subject.departmentDepartment of Physics and Astronomy
dc.subject.departmentDivision of Medical Sciences
dc.subject.departmentSchool of Medical Sciences
dc.titleInvestigation of Nano-Bio Interactions within a Pancreatic Tumor Microenvironment for the Advancement of Nanomedicine in Cancer Treatmenten_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Alhussan_Abdulaziz_CurrOncol_2021.pdf
Size:
2.23 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2 KB
Format:
Item-specific license agreed upon to submission
Description: